RegenLife Centers · Physician-led care
Pelvic Pain Treatment Cincinnati OH
Causes and Regenerative Solutions
Published on October 11th, 2026


Persistent symptoms can cause exhaustion when standard care does not provide a clear explanation or lasting relief.
Pelvic pain treatment in Cincinnati, OH at RegenLife Centers for Integrative Pain & Weight Management starts from a different premise: that chronic pelvic pain is a whole-person problem requiring a whole-person evaluation, and that the structural, hormonal, myofascial, and neurological contributors to pelvic pain each require specific identification and treatment rather than a sequential trial of interventions that address symptoms rather than causes. Chronic pelvic pain affects an estimated 6–27% of women aged 18–50 worldwide, and a significant subset of men, yet it remains one of the most chronically undertreated conditions in pain medicine, because its causes are multifactorial, its presentations overlap across specialties, and its most effective regenerative treatments fall outside the scope of what standard gynecological or orthopedic evaluations typically offer.
Woman sitting in bed holding her stomach, indicating pain or discomfort, possibly due to cramps.Key Takeaways
- Chronic pelvic pain affects 6–27% of women aged 18–50 worldwide and 2–16% of men: yet standard evaluations frequently miss the structural, myofascial, and hormonal contributors that drive the majority of cases, leaving patients cycling through treatments that address the wrong generator
- PRP therapy for pelvic floor disorders showed a subjective success rate of 89% for pelvic organ prolapse and 90% improvement in stress urinary incontinence in clinical studies, with fewer than 1% of patients experiencing adverse events: establishing PRP as an emerging and well-tolerated regenerative option
- Myofascial trigger points in the pelvic floor musculature are responsible for a substantial proportion of chronic pelvic pain that is misattributed to gynecological or urological pathology, and respond to a combination of trigger point injection, manual therapy, and targeted pelvic floor rehabilitation
- Hormonal deficiency: estrogen in women, testosterone in both sexes, amplifies pelvic pain sensitivity, reduces connective tissue healing capacity, and sustains the pain cycle independently of the structural generators that interventional and regenerative treatment must also address
Understanding Chronic Pelvic Pain: What Standard Evaluation Misses
The Definition and Scope of the Condition
Chronic pelvic pain is defined clinically as persistent or recurrent pain in the lower abdomen or pelvis lasting at least 3–6 months, pain severe enough to cause functional impairment or require medical care. The condition is not rare. Globally, chronic pelvic pain affects between 6% and 27% of women aged 18–50, and while women bear the larger burden, 2–16% of chronic pelvic pain cases occur in men, primarily through chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a condition that shares both the mechanism and the diagnostic frustration of its female counterpart.
The disorder is not a single condition but a clinical syndrome, a convergence point for multiple pain generators across reproductive, urological, gastrointestinal, musculoskeletal, and neurological systems, each capable of producing pelvic pain independently and often simultaneously. 70% of endometriosis patients develop chronic pelvic pain; 61% of women with bladder pain syndrome report concurrent pelvic pain beyond the bladder itself; and 35% of chronic pelvic pain patients carry a comorbid diagnosis of irritable bowel syndrome, figures that illustrate both the complexity of the condition and the reason that single-specialty evaluation so consistently fails to identify its complete source.
Why the Standard Workup Leaves So Many Patients Without Answers
The conventional approach to pelvic pain, gynecological examination, pelvic ultrasound, and laparoscopic referral if endometriosis is suspected, identifies some causes and misses others systematically. What it does not evaluate: the myofascial trigger point load in the pelvic floor musculature, the ligamentous laxity of the sacroiliac and pubic symphysis joints, the hormonal deficiency amplifying pain sensitivity, or the autonomic nervous system dysregulation sustaining central sensitization. These are not peripheral contributors. They are, in many patients, the primary drivers of pain, and they require a different evaluation framework to identify.
Diagnostic services at RegenLife assess pelvic pain from the structural, hormonal, and systemic dimensions that standard evaluations are not designed to capture, a necessary prerequisite for treatment that addresses the whole pain picture rather than only the most visible finding.
Acute vs. Chronic: Knowing When to Seek Urgent Care
Not all pelvic pain is chronic, and some presentations require immediate attention. Sudden-onset severe pelvic pain, particularly when accompanied by fever, vaginal bleeding, or abdominal rigidity, may indicate ectopic pregnancy, ovarian torsion, pelvic inflammatory disease, or appendicitis, all of which require emergency assessment. Chronic pelvic pain, by contrast, follows a pattern of persistent or recurrent discomfort lasting beyond the 3–6 month diagnostic threshold, often with identifiable triggers and predictable patterns that point toward structural, hormonal, or myofascial rather than surgical-emergency causes. Distinguishing between these presentations determines whether the clinical pathway leads toward urgent intervention or toward the comprehensive evaluation that chronic pelvic pain requires.
The Structural and Musculoskeletal Causes of Pelvic Pain
A therapist assists a patient during a physical therapy session in an indoor clinical settingPelvic Floor Myofascial Dysfunction
The pelvic floor is a complex of muscles, ligaments, and fascial structures spanning the base of the pelvis, providing support for the bladder, bowel, and reproductive organs while coordinating continence and sexual function. Myofascial trigger points, hyperirritable nodules within the pelvic floor musculature, are responsible for a substantial proportion of chronic pelvic pain that is attributed to gynecological or urological pathology without ever identifying the muscular source. When pelvic floor muscles develop trigger points from trauma, prolonged protective guarding, postural dysfunction, or the chronic inflammation of associated conditions like endometriosis, they produce a characteristic pattern of local and referred pain: deep pelvic aching, dyspareunia, urgency and frequency, and pain with prolonged sitting, a symptom profile that mimics multiple other diagnoses closely enough to generate years of misdirected treatment.
Clinical identification of pelvic floor trigger points requires internal vaginal or rectal palpation, an examination not standard in most gynecological or primary care evaluations. When trigger points are identified and treated through a combination of trigger point injection, manual therapy, and pelvic floor physical therapy, the pain relief can be substantial. A multimodal approach targeting pelvic floor trigger points, combining physical therapy, massage therapy, and targeted injection, is the current evidence-based standard for myofascial pelvic pain management.
Sacroiliac Joint and Pelvic Ligamentous Contributions
The pelvis is not a static structure. The sacroiliac joints, pubic symphysis, and the network of pelvic ligaments connecting the sacrum to the ilium are subject to the same laxity, instability, and structural failure that drive sacroiliac joint dysfunction in the lower back, and when they become hypermobile or degenerated, they generate pain that radiates directly into the pelvic basin, the groin, the inner thigh, and the lower abdominal region. Hormonal laxity during pregnancy, mediated by relaxin, is the most common precipitant of pelvic ligamentous instability in women, but prior pelvic trauma, repetitive athletic loading, and the progressive connective tissue changes of estrogen deficiency can produce equivalent structural vulnerability.
Prolotherapy, the injection of a proliferant dextrose solution into the affected ligament insertions, initiates the collagen repair and ligament tightening that restores structural stability, addressing the pain generator directly rather than suppressing the signal it produces. For presentations involving both ligamentous instability and intra-articular joint pathology, the detailed approach to sacroiliac joint PRP and prolotherapy applies directly to pelvic pain sourced from the posterior pelvic ring.
Interstitial Cystitis, Endometriosis, and Overlapping Pain Generators
Interstitial cystitis and endometriosis represent two of the most common structural conditions associated with chronic pelvic pain, and they frequently co-occur, compounding each other's contribution. Endometriosis produces pelvic pain through direct tissue inflammation and the local release of prostaglandins; interstitial cystitis through bladder wall inflammation and the viscerosomatic referred pain it generates in surrounding musculature. Both conditions are commonly accompanied by secondary pelvic floor muscular guarding and trigger point formation, meaning that even when the primary diagnosis is accurate, the myofascial component requires independent treatment for complete pain resolution. Treating only the primary condition while leaving the secondary myofascial layer untouched produces improvement that plateaus before it reaches functional normalcy.
Hormonal and Systemic Contributors to Pelvic Pain
Estrogen, Testosterone, and the Pain Sensitivity Threshold
The pelvic floor, pelvic ligaments, and pelvic organ surfaces are hormone-sensitive structures. Estrogen deficiency, from menopause, premature ovarian insufficiency, or relative estrogen suppression from excessive exercise, reduces tissue quality throughout the pelvic floor, thins pelvic ligaments and epithelial surfaces, and significantly increases pain sensitivity by lowering the peripheral pain threshold at estrogen-receptor-containing nerve endings. The result is a biological environment in which the same mechanical stimulus or inflammatory load produces substantially greater pain than it would in an estrogenically adequate patient.
Testosterone, often overlooked in female pelvic health, plays a parallel role. Vestibular and perineal tissues contain testosterone receptors, and testosterone deficiency, which occurs in women as well as men with hormonal disruption, contributes to pelvic tissue atrophy, reduced pain tolerance, and heightened nerve sensitivity. Identifying and correcting these hormonal deficiencies through hormone therapy creates the biological foundation in which regenerative treatment achieves its full structural repair effect, rather than treating tissue that lacks the hormonal resources to complete the repair.
The Autonomic Nervous System, Stress, and Central Sensitization
Chronic pelvic pain is not simply a local tissue phenomenon. The autonomic nervous system connects the pelvis to the brain through a dense network of sympathetic and parasympathetic fibers, and chronic sympathetic overactivation, the sustained stress-response state produced by chronic pain, trauma, and sleep disruption, maintains pelvic muscle guarding, amplifies visceral pain signals, and sustains the central sensitization that causes the brain to generate pain out of proportion to actual tissue damage. This is the mechanism behind conditions like vulvodynia and non-bacterial prostatitis, where pain persists in the apparent absence of active tissue pathology because the nervous system has been recalibrated to a pain-amplified state.
ANS testing at RegenLife provides objective measurement of this autonomic imbalance, heart rate variability analysis, sympathovagal balance assessment, and quantification of the chronic sympathetic activation that predicts poor treatment response until the neurological environment is addressed alongside the structural one. BrainTap neurostimulation and behavioral health support target this autonomic contribution directly, recalibrating the nervous system environment in which all other treatments operate.
Inflammatory Load and Metabolic Health in Pelvic Pain
Systemic inflammation from insulin resistance, visceral adiposity, and chronic metabolic disease directly amplifies pelvic pain through elevated prostaglandins, cytokines, and central sensitizing compounds. A patient with uncontrolled blood glucose and visceral adiposity carries a baseline inflammatory burden that sustains pelvic pain independently of its structural generators, and that impairs the tissue repair response to every regenerative treatment applied without first addressing the metabolic environment. Diagnostic services that include fasting insulin, high-sensitivity CRP, and full inflammatory markers identify this systemic load and guide the lifestyle medicine and metabolic interventions that reduce it, creating the biological conditions in which regenerative treatment can work as intended.
PRP Therapy for Pelvic Pain and Pelvic Floor Disorders
Close-up of a healthcare professional drawing blood for PRP preparation in a clinical settingHow PRP Works in Pelvic Applications
PRP therapy for pelvic conditions follows the same biological principle that makes it effective for joint and tendon pathology: the patient's own blood is drawn, centrifuged to concentrate the platelet fraction 3–8 times above baseline, and the resulting growth factor payload, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF), is delivered under image guidance into damaged or degenerating pelvic tissue. These growth factors directly stimulate tissue regeneration, collagen synthesis, and vascular remodeling in the injected structures, the ligamentous supports of the pelvic floor, the stressed tissues around the urethrovesical junction in urinary incontinence, and the degenerated connective tissue in pelvic organ prolapse.
PRP's application in urogynecology represents one of the newer frontiers of regenerative medicine, with a clinical evidence base that has grown substantially over the last five years as standardized preparation and delivery protocols have emerged and clinical trials have produced reproducible outcome data.
The Clinical Evidence: PRP for Pelvic Floor Conditions
The evidence base for PRP in pelvic floor disorders is compelling and growing. A systematic review analyzing 15 studies involving 600 women with pelvic floor disorders, including stress urinary incontinence, pelvic organ prolapse, female sexual dysfunction, and vulvovaginal atrophy, found significant improvements across multiple outcome measures and study designs, with female sexual function index (FSFI) scores, SUI visual analog scores, and vaginal health indices all demonstrating statistically significant improvement (p < 0.001 across multiple metrics).
For stress urinary incontinence specifically, one clinical study found that 90% of patients receiving PRP injections experienced an improvement of at least 50%, a clinically meaningful threshold in a condition that substantially reduces quality of life. A 2025 scoping review covering 320 patients across 13 manuscripts found that PRP therapy for pelvic floor conditions demonstrated high subjective improvement rates with fewer than 1% of patients, 3 out of 317, experiencing any adverse events, establishing PRP as a well-tolerated regenerative option for this population.
For pelvic organ prolapse, a randomized controlled trial found an 89% subjective success rate following PRP injection, with only 3.8% of patients experiencing symptomatic anatomic recurrence, compared to substantially higher recurrence rates in control groups, and significantly lower reoperation rates in the PRP-treated cohort.
PRP for Pelvic Ligamentous Pain and Structural Instability
Beyond urogynecological applications, PRP therapy addresses the ligamentous instability and joint degeneration that generate pelvic pain through structural rather than visceral mechanisms. The regenerative program at RegenLife applies PRP to sacroiliac joint dysfunction, pubic symphysis instability, and pelvic ligamentous laxity, conditions that produce deep pelvic and groin pain frequently misattributed to gynecological or urological sources. In these structural applications, PRP delivers a concentrated growth factor payload that stimulates repair of the ligamentous structures whose failure is generating the pain, the same mechanism that makes it effective in tendon and joint pathology elsewhere in the musculoskeletal system.
The interventional procedures that precede or accompany PRP, diagnostic nerve blocks confirming the pain source, image-guided injections ensuring precise delivery, provide the clinical infrastructure that makes regenerative treatment reliable rather than approximate.
Prolotherapy for Pelvic Ligamentous Instability
How Prolotherapy Addresses Structural Pelvic Pain
Prolotherapy for pelvic pain targets the ligamentous structures that provide the passive stability of the pelvic girdle, the sacroiliac ligaments, the iliolumbar ligaments, and the sacrospinous and sacrotuberous ligaments, structures that, when overstretched or chronically inflamed, generate pain that radiates into the pelvis, groin, buttock, inner thigh, and lower abdominal region. The injection of concentrated dextrose solution into these ligament insertions triggers a controlled local inflammatory response that recruits the repair cells and growth factors required for collagen proliferation and ligament tightening, structural stabilization of the pelvic girdle at the level where instability is occurring rather than downstream symptom management.
For postpartum women with residual pelvic ligamentous laxity from relaxin-mediated pregnancy changes, for patients with prior pelvic trauma that never fully stabilized, and for individuals whose connective tissue has been progressively weakened by estrogen deficiency, prolotherapy addresses the mechanical cause of their pain. The treatment protocol most supported by evidence involves 3 injection sessions at 6-week intervals, allowing each session's repair response to progress before the next stimulus is applied, a cadence designed around the biological timeline of connective tissue repair rather than administrative convenience.
Combining Prolotherapy and PRP for Complex Presentations
In patients with both intra-articular joint pathology and ligamentous laxity, combining prolotherapy and PRP within a structured treatment protocol leverages the complementary mechanisms of both approaches. Prolotherapy generates the repair stimulus at ligament insertions where dextrose's inflammatory mechanism is most effective; PRP delivers the more complex growth factor payload where tissue regeneration, cartilage, connective tissue, pelvic floor support structures, requires the full biological signal that concentrated platelets provide. This combined approach, sequenced appropriately around each component's biological repair timeline, can address both the structural and the tissue-quality dimensions of complex pelvic pain presentations in fewer total sessions than either modality applied alone would require.
Physical Rehabilitation, Pelvic Floor Therapy, and Manual Care
A trainer coaching a woman through a pelvic floor exercise on a yoga mat indoorsPelvic Floor Physical Therapy: The Evidence Base
Pelvic floor physical therapy is the best-documented conservative intervention for chronic pelvic pain. Patients completing structured pelvic floor physical therapy use 22% fewer pain medications than those receiving standard care alone, a meaningful reduction in pharmacological burden that reflects the direct impact of addressing muscular dysfunction rather than managing its downstream symptom. Trained pelvic floor physical therapists identify the pattern of hypertonia or hypotonia in each patient's pelvic musculature, locate active trigger points generating referred pain and functional symptoms, and apply manual therapy, biofeedback, and therapeutic exercise to normalize muscle function and resolve the pain generators directly.
Physical therapy at RegenLife addresses pelvic floor dysfunction through a protocol designed around each patient's specific structural findings, not a generic program applied uniformly across presentations, but a targeted intervention that responds to the actual pattern of muscular dysfunction, joint restriction, and movement impairment driving that patient's pain.
Exercise Therapy and Functional Recovery
Exercise therapy for pelvic pain follows the structural diagnosis. Patients whose pain derives from ligamentous laxity and pelvic floor hypermobility require stabilization-focused exercise targeting the deep stabilizing muscles, the transverse abdominis, the pelvic floor itself, and the hip external rotators and gluteal musculature that provide dynamic pelvic girdle stability when passive ligamentous support has been compromised. Patients with hypertonic, overly guarded pelvic floor muscles require a different approach, progressive relaxation, movement patterning, and coordination training before any strengthening is appropriate.
The transition from pelvic floor dysfunction to functional recovery also encompasses gait retraining, postural correction, and the progressive return to activities that the pain had previously restricted, all of which exercise therapy at RegenLife structures around the individual's presentation and the biological repair timeline that regenerative treatment establishes.
Chiropractic Care and Manual Therapy
The sacroiliac joint and lumbar spine are biomechanically continuous with the pelvic girdle, and segmental dysfunction at the L4-L5 or L5-S1 levels, or at the SI joint itself, regularly contributes to the pelvic pain picture through referred pain and compensatory muscle guarding. Physical therapy at RegenLife addresses these restrictions through targeted joint mobilization, soft-tissue work, and movement retraining that restore normal mechanics and create the environment in which regenerative treatment can produce its full cumulative effect. The sequencing, regenerative treatment to restore ligamentous integrity, followed by manual therapy to restore normal motion patterns, followed by rehabilitation to build dynamic stabilization, reflects the biological logic of the whole-system approach RegenLife applies to complex pelvic pain presentations.
Comprehensive Evaluation and the RegenLife Approach to Pelvic Pain Treatment in Cincinnati OH
What a Whole-Person Diagnostic Workup Looks Like
Effective pelvic pain treatment in Cincinnati, OH begins with a diagnostic evaluation designed to identify all contributing factors rather than stopping at the most obvious one. At RegenLife, the assessment process includes comprehensive laboratory evaluation, fasting insulin, high-sensitivity CRP, full thyroid panel, sex hormone levels including free and total estradiol, testosterone, and DHEA-S, alongside ANS testing that quantifies autonomic nervous system dysregulation, and structural assessment of the musculoskeletal contributors that imaging alone cannot identify. This diagnostic breadth reflects the clinical reality that pelvic pain is almost never generated by a single factor: the patient with endometriosis-related pelvic pain also commonly carries pelvic floor trigger points, SI joint laxity from prior pregnancy, and estrogen deficiency that is amplifying every signal, and treating the endometriosis without addressing the other three produces improvement that plateaus before it reaches functional recovery.
Integrating Care Across the Full Pelvic Pain Picture
The RegenLife model, integrating pain management, regenerative procedures, physical therapy, hormone therapy, lifestyle medicine, and behavioral health under one practice, is particularly well-suited to pelvic pain, which characteristically requires exactly this range of coordinated intervention. Instead of sequential specialist referrals that each address one dimension while leaving others untouched, RegenLife's integrated approach identifies and treats the structural, hormonal, myofascial, metabolic, and neurological contributors to each patient's pelvic pain simultaneously, which is the clinical structure that the complexity of this condition actually requires and that standard single-specialty care is structurally unable to deliver.
Contact RegenLife Centers to schedule an evaluation or ask which service fits your needs.
Frequently Asked Questions
Find answers to common questions
Ready to Learn More?
To learn more and to find out if you might be a good candidate at RegenLife, schedule a consultation with our team today.
About the Author

Caitlyn Benton, Research Manager at RegenLife
As Research Manager, Caitlyn Benton oversees the strategic planning and execution of clinical research projects, ensuring all studies adhere to the highest regulatory and ethical standards. With expertise in protocol development and data monitoring, she coordinates multidisciplinary teams to ensure the integrity of our clinical research programs and the accuracy of the insights shared with our patients.
Reviewed and Approved by

Dr. Zeeshan Tayeb, Medical Director at RegenLife
Interventional Spine, Pain, and Sports Medicine Dr. Zeeshan Tayeb, MD is board-certified in Pain Medicine and Physical Medicine & Rehabilitation, with specialized fellowship training in interventional spine, pain, and sports medicine. He sees patients at Pain Specialists of Cincinnati/RegenLife in Cincinnati, Ohio. Dr. Tayeb's background in physical medicine and rehabilitation has provided the foundation for his comprehensive approach to treating the whole person. Dr. Tayeb has done extensive training and education in both functional and regenerative medicine and specializes in state-of-the-art treatments, including laser therapies, PRP and stem-cell injections, and nutritional and hormonal optimization.
Disclaimer:
As a service to our readers, RegenLife provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Stay Updated With Our Latest News
Check back regularly for new articles and updates about pain management treatments, practice news, and health tips from our team of specialists.
Get In Touch
Same-week consults. Real follow-through.
Tell us what's going on. A coordinator will follow up during office hours to help book your visit.
Choose the clinic that works for you.
Most new patients can be seen within the same week.
We accept most major insurance plans